Article · Volume 14, Issue 4 · pp. 294–297
Case Report on Anti-Tubercular Drug Induced Hepatoxicity / Modified ATT
M Saru Khan1, Basil Sunny2, Rithuvaren M Krishnan3
- 1Department of Pharmacy Practice, Annai JKK Sampoorani Ammal College of Pharmacy, Erirmedu, Namakkal, Tamil Nadu, INDIA.
- 2Manager and Clinical Pharmacologist of Sun Rise Hospital, Kochi, Kerala, INDIA.
- 3Annai JKK Sampoorani Ammal College of Pharmacy, Tamil Nadu, INDIA.
Abstract
This case summary focusing on a 67-year male patient admitted in Sun rise Hospital, Kochi with k/c/o active tubercular on cat.2 ATT, now patient came complaint with c/o decreased appetite, food intake, nausea, vomiting and excessive fatigability. The patient was received first line anti tubercular drugs 6 months back RHZE (Rifampin, Pyrazinamide, Ethambutol, and Isoniazid) and discontinued medication 2 months back. Now it is developed a severe hepatitis which is an adverse drug reaction of the Antitubercular drugs.
Keywords: Hepatitis; Adverse drug reaction of anti-TB drug; Treatment; Pulmonary Koch infection; ALT; AST; Modified att
The full text of this article is available as a PDF. Open the PDF.